NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Investigators at University of Verona publish new data on breast cancer



August 7th, 2008

" The aim of this study was to compare a pure macromolecular contrast agent (Gd-DTPA-albumin) with a new protein-binding blood pool contrast agent (B22956/1) in terms of their capacity to investigate the microvasculature in an experimental model of mammary carcinoma. Materials and methods Tumors were induced by subcutaneous injection of 5 x 10(5) BB1 cells into the backs of 5-7 week-old female FVB/neuNT233 mice," scientists writing in the journal Magnetic Resonance Materials in Physics Biology and Medicine report.

"The animals were observed using DCE-MRI when the longest diameter of the tumor was 10.2 +/- 2.0 mm. DCE-MRI experiments were carried out using...


Source: Women's Health Weekly (2008-08-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login